| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/25/2004 | CA2498367A1 Viral deconstruction through capsid assembly in vitro |
| 03/25/2004 | CA2498308A1 Parathyroid hormone-like polypeptides |
| 03/25/2004 | CA2498274A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 03/25/2004 | CA2498249A1 Ostertagia vaccine |
| 03/25/2004 | CA2498008A1 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | CA2498004A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | CA2498000A1 Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
| 03/25/2004 | CA2497804A1 Human anti-human mcp-1 antibody and fragment of said antibody |
| 03/25/2004 | CA2497661A1 Compositions and methods for the diagnosis of immune related diseases using pro71061 |
| 03/25/2004 | CA2497364A1 Protein purification method |
| 03/25/2004 | CA2497337A1 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | CA2496060A1 Protein purification by ion exchange chromatography |
| 03/24/2004 | EP1400592A1 Streptococcus pneumoniae polynucleotides and sequences |
| 03/24/2004 | EP1400591A1 Agent for treatment of exocrine gland disorders and transgenic mouse useful for screening the same |
| 03/24/2004 | EP1400536A1 Method for making humanized antibodies |
| 03/24/2004 | EP1400535A1 Therapeutic anti-BGP (C-CAM1) antibodies and uses thereof |
| 03/24/2004 | EP1400534A1 Human CD3-specific antibody with immunosuppressive properties |
| 03/24/2004 | EP1400532A1 M. paratuberculosis specific ABC-transporter operon |
| 03/24/2004 | EP1400174A1 Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk |
| 03/24/2004 | EP1400171A1 Transgenic production of antibodies in milk |
| 03/24/2004 | EP1399744A2 Epf receptor assays, compounds and therapeutic compositions |
| 03/24/2004 | EP1399739A2 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 03/24/2004 | EP1399592A1 Method to measure gene expression ratio of key genes |
| 03/24/2004 | EP1399587A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 03/24/2004 | EP1399584A2 Cancer-linked genes as targets for chemotherapy |
| 03/24/2004 | EP1399580A1 Secretion of proteins by encapsulated cells |
| 03/24/2004 | EP1399570A2 Peptides for use as translocation factors |
| 03/24/2004 | EP1399565A2 Mitogenic oxygenase regulators |
| 03/24/2004 | EP1399559A2 Mouse lambda light chain locus |
| 03/24/2004 | EP1399558A2 Vanilloid receptor-related nucleic acids and polypeptides |
| 03/24/2004 | EP1399556A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399553A2 Polynucleotides encoding cellular transporters and methods of use therof |
| 03/24/2004 | EP1399552A2 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |
| 03/24/2004 | EP1399549A1 Anticomplement polypeptide from salivary glands of the tick ixodes ricinus |
| 03/24/2004 | EP1399484A2 Dual-specific ligand and its use |
| 03/24/2004 | EP1399483A2 Antibodies to insulin-like growth factor i receptor |
| 03/24/2004 | EP1399482A2 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 03/24/2004 | EP1399481A1 Recombinant antibodies against infectious bursal disease virus (ibdv) |
| 03/24/2004 | EP1399478A2 Cancer-testis antigens |
| 03/24/2004 | EP1399461A2 Nucleotide sequences encoding variable regions of heavy and light chains of monoclonal antibody 1f7 |
| 03/24/2004 | EP1399187A2 Uses of monoclonal antibody 8h9 |
| 03/24/2004 | EP1399185A2 Use of polyclonal immunoglobulins as vaccine |
| 03/24/2004 | EP1399181A2 Peptide vaccines against group a streptococci |
| 03/24/2004 | EP1399180A2 Sulfated ccr5 peptides for hiv-1 infection |
| 03/24/2004 | EP1399178A2 Method of treating metabolic disorders using neuronatin polypeptides |
| 03/24/2004 | EP1399175A2 Therapeutic use of rank antagonists |
| 03/24/2004 | EP1399162A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 03/24/2004 | EP1399110A2 Antibodies abolish prion propagation and promote clearance of infectivity |
| 03/24/2004 | EP1399016A2 Method for generating diversity |
| 03/24/2004 | EP0796277B1 Fusion junction type iii mutant egf receptor peptide tumour vaccine |
| 03/24/2004 | EP0625212B1 Methods of detecting alzheimer's disease |
| 03/24/2004 | CN1484699A Novel mutant allergens |
| 03/24/2004 | CN1484652A Antibodies to human IL-1 beta |
| 03/24/2004 | CN1484650A Urocortin proteins and uses thereof |
| 03/24/2004 | CN1483741A Novel human protein with cancer-suppressing function and coding sequence thereof |
| 03/24/2004 | CN1483740A Novel human protein with function for suppressing cancer and coding sequence thereof |
| 03/24/2004 | CN1483739A Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof |
| 03/24/2004 | CN1483738A Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof |
| 03/24/2004 | CN1483737A Specific protein of SARS virus, clinical detection method and kit |
| 03/24/2004 | CN1142996C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 03/23/2004 | US6710226 Administering agent to induce immune response against amyloid deposit; drug screening, vaccines |
| 03/23/2004 | US6710171 Isolated dna encoding protein having specified amino acid sequence; treating or preventing arteriosclerosis and restenosis after treatment of artery occlusion |
| 03/23/2004 | US6710169 Adheson variants |
| 03/23/2004 | US6710163 Compounds that bind single-stranded dna and rna strands to form stable hybrids; bind complementary single-stranded dna and rna strands more strongly than corresponding dna |
| 03/23/2004 | US6710026 Diabetes |
| 03/23/2004 | US6709873 Administering to animal immunogen comprising rapamycin compound conjugated to protein carrier by divinyl sulfone linker arm to effect specific antibody response, recovering antibody which recognizes region located between c9 and c23 |
| 03/23/2004 | US6709842 DNA encoding a growth factor specific for epithelial cells |
| 03/23/2004 | US6709839 SYK-UBP proteins, compositions and methods of use |
| 03/23/2004 | US6709838 Nucleic acid encoding patched-2 |
| 03/23/2004 | US6709837 Reagent for studies relating to the differentiation, growth and survival of animal cells, and may also be useful as a drug |
| 03/23/2004 | US6709833 Antibody for use as tool in immunoassay |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709811 Versatile reagent for detecting murine leukemia viruses |
| 03/23/2004 | US6709660 Meningococcal antigens |
| 03/23/2004 | US6709656 Polyclonal and/or monoclonal immunoglobulin immunization |
| 03/23/2004 | US6709655 Pharmaceutical composition of F(ab1)2 antibody fragments and a process for the preparation thereof |
| 03/23/2004 | US6709654 Treatment of psoriasis using anti-B7.1 (CD80) antibodies |
| 03/19/2004 | CA2402930A1 Targeted ligands |
| 03/18/2004 | WO2004022770A2 Compositions and methods for synthesizing nucleic acids |
| 03/18/2004 | WO2004022769A2 Means of detecting neurodegenerative processes and applications of same |
| 03/18/2004 | WO2004022768A1 Arachidonic acid metabolites and modulation of mitosis and apoptosis of cells |
| 03/18/2004 | WO2004022754A1 CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE |
| 03/18/2004 | WO2004022752A1 Smg-1-binding protein and method of screening substance controlling its activity |
| 03/18/2004 | WO2004022750A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | WO2004022746A1 In vitro peptide expression libraray |
| 03/18/2004 | WO2004022739A1 Antibody against n-terminal peptide or c-terminal peptide of gpc3 solubilized in blood |
| 03/18/2004 | WO2004022718A2 Therapeutic human anti-il-1r1 monoclonal antibody |
| 03/18/2004 | WO2004022717A2 Minimally immunogenic variants of humanized col-1 antibody against carcinoembryonic antigen |
| 03/18/2004 | WO2004022713A2 Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca) |
| 03/18/2004 | WO2004022709A2 Epitope sequences |
| 03/18/2004 | WO2004022706A2 Immune cell receptor ligand and immune cell receptor |
| 03/18/2004 | WO2004022697A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | WO2004022599A1 Fused antibody and method of constructing the same |
| 03/18/2004 | WO2004022597A1 Antibody against blood-solubilized n-terminal peptide in gpc3 |
| 03/18/2004 | WO2004022596A1 Monoclonal antibody against adiponectin, preparation method and use thereof |
| 03/18/2004 | WO2004022595A1 CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE |
| 03/18/2004 | WO2004022097A1 Methods of preventing or treating cell malignancies by administering cd2 antagonists |
| 03/18/2004 | WO2004022096A1 Method of treatment of asthma using antibodies to complement component c5 |
| 03/18/2004 | WO2004022095A1 Anti-idiotypic antibodies as vegf or fgf agonists for bone therapy |